AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics.
AbbVie has raised $8.0B in total funding. The most recent round was Post-IPO Debt. The last funding was announced in February 2026.
AbbVie is headquartered in North Chicago, United States.
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics.
AbbVie is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AbbVie — Funding & Investors." VCBacked, February 26, 2026, https://www.vcbacked.co/company/abbvie. Accessed August 13, 2026.
VCBacked. (2026). AbbVie — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/abbvie
{{cite web |title=AbbVie — Funding & Investors |url=https://www.vcbacked.co/company/abbvie |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated